Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01921686 · ClinicalTrials.gov registry record
Morphological Markers of Gastroesophageal Reflux Disease (GERD)
A clinical trial of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease, sponsored by Baylor College of Medicine.
- Active
- Registry status
- 54
- Enrollment target
- 1
- Study location
NCT01921686: Active study of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease, sponsored by Baylor College of Medicine.
NCT01921686 is a study of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 54 participants, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01921686, a study of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease, is active but no longer recruiting, sponsored by Baylor College of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to learn more about a new and promising way to diagnose acid reflux disease using a very high-powered microscope. This special microscope provides much finer detail than typical microscopes previously used for diagnosing reflux, and may help doctors to better identify children with acid reflux.
Conditions Studied
Interventions
- OTHER Sample collection and Questionnaire
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2013-03 |
| Est. Completion | 2026-12 |
What the registry record for NCT01921686 still lists
NCT01921686 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which Sample collection and Questionnaire is the first listed.
NCT01921686 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01921686 about?
NCT01921686 is a clinical study titled "Morphological Markers of Gastroesophageal Reflux Disease (GERD)". The purpose of this project is to learn more about a new and promising way to diagnose acid reflux disease using a very high-powered microscope. This special microscope provides much finer detail than typical microscopes previously used for diagnosing reflux, and may help doctors to better identify ...
What is the current status of trial NCT01921686?
This trial is currently active not recruiting. The enrollment target is 54 participants. The study started on 2013-03. Estimated completion is 2026-12.
What conditions does trial NCT01921686 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis, Gastroesophageal Reflux Disease.
What interventions are being tested in trial NCT01921686?
The interventions under investigation include: Sample collection and Questionnaire (OTHER).
Who is sponsoring clinical trial NCT01921686?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01921686 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01921686's enrollment target sits among peer trials
54 27th of 44 higher than 17 of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)
RECRUITING
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
A Registry for the Food Allergy Community
RECRUITING
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
Eosinophilic Gastrointestinal Disorders Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia